Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity

被引:72
作者
Rasolofonjatovo, Evelia [1 ]
Provot, Olivier [1 ]
Hamze, Abdallah [1 ]
Rodrigo, Jordi [1 ]
Bignon, Jerome [2 ]
Wdzieczak-Bakala, Joanna [2 ]
Desravines, Deborah [2 ]
Dubois, Joelle [2 ]
Brion, Jean-Daniel [1 ]
Alami, Mouad [1 ]
机构
[1] Univ Paris Sud, BioCIS UMR 8076, Fac Pharm, Chim Therapeut Lab,LabEx LERMIT,CNRS, F-92296 Chatenay Malabry, France
[2] Inst Chim Subst Nat, UPR 2301, F-91198 Gif Sur Yvette, France
关键词
Combretastatin A-4; isoCA-4; Cytotoxicity; Antimitotic; Tubulin; Restricted analogues; COMBRETASTATIN A-4; ANTINEOPLASTIC AGENTS; ARYL HALIDES; BIOLOGICAL EVALUATION; ANTITUMOR-ACTIVITY; N-TOSYLHYDRAZONES; TUBULIN; ACCESS; DIARYLALKYNES; MECHANISMS;
D O I
10.1016/j.ejmech.2012.03.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of dihydronaphtalene, tetrahydronaphtalene and naphtalene derivatives as restricted analogues of isoCA-4 were designed, synthesized and evaluated for their anticancer properties. High cell growth inhibition against four tumour cell lines was observed at a nanomolar level with dihydronaphtalenes 1d, e and 1h, tetrahydronaphtalene 2c and naphtalene 3c. Structure activity relationships are also considered. These compounds exhibited a significant inhibitory activity toward tubulin polymerization (IC50 = 2-3 mu M), comparable to that of isoCA-4. The effect of the lead compounds le and 2c on the cancer cells tested was associated with cell cycle arrest in the G(2)/M phase. Docking studies reveal that these compounds showed a binding mode similar to those observed with their non-constraint isoCA-4 and isoerianin congeners. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:22 / 32
页数:11
相关论文
共 50 条
[1]   AN EFFICIENT PALLADIUM-CATALYZED REACTION OF VINYL AND ARYL HALIDES OR TRIFLATES WITH TERMINAL ALKYNES [J].
ALAMI, M ;
FERRI, F ;
LINSTRUMELLE, G .
TETRAHEDRON LETTERS, 1993, 34 (40) :6403-6406
[2]   The selective reaction of aryl halides with KOH: Synthesis of phenols, aromatic ethers, and benzofurans [J].
Anderson, Kevin W. ;
Ikawa, Takashi ;
Tundel, Rachel E. ;
Buchwald, Stephen L. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (33) :10694-10695
[3]   In vitro metabolism study of combretastatin A-4 in rat and human liver Microsomes [J].
Aprile, Silvio ;
Del Grosso, Erika ;
Tron, Gian Cesare ;
Grosa, Giorgio .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (12) :2252-2261
[4]   N-tosylhydrazones as reagents for cross-coupling reactions:: A route to polysubstituted olefins [J].
Barluenga, José ;
Moriel, Patricia ;
Valdes, Carlos ;
Aznar, Fernando .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2007, 46 (29) :5587-5590
[5]   A fluorescence-based high-throughput assay for antimicrotubule drugs [J].
Barron, DM ;
Chatterjee, SK ;
Ravindra, R ;
Roof, R ;
Baloglu, E ;
Kingston, DGI ;
Bane, S .
ANALYTICAL BIOCHEMISTRY, 2003, 315 (01) :49-56
[6]   Natural, semisynthetic and synthetic microtubule inhibitors for cancer therapy [J].
Beckers, T ;
Mahboobi, S .
DRUGS OF THE FUTURE, 2003, 28 (08) :767-785
[7]   Pd-Catalyzed Reaction of Sterically Hindered Hydrazones with Aryl Halides: Synthesis of Tetra-Substituted Olefins Related to iso-Combretastatin A4 [J].
Brachet, Etienne ;
Hamze, Abdallah ;
Peyrat, Jean-Francois ;
Brion, Jean-Daniel ;
Alami, Mouad .
ORGANIC LETTERS, 2010, 12 (18) :4042-4045
[8]   Mechanisms of action of and resistance to antitubulin agents: Microtubule dynamics, drug transport, and cell death [J].
Dumontet, C ;
Sikic, BI .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :1061-1070
[9]   Microtubule targeting agents: Basic mechanisms of multidrug resistance (MDR) [J].
Fojo, AT ;
Menefee, M .
SEMINARS IN ONCOLOGY, 2005, 32 (06) :S3-S8
[10]   Motor neuropathy due to docetaxel and paclitaxel [J].
Freilich, RJ ;
Balmaceda, C ;
Seidman, AD ;
Rubin, M ;
DeAngelis, LM .
NEUROLOGY, 1996, 47 (01) :115-118